11AM Hour: Moderna and Merck Shares Surge, Former CEA Chair Jason Furman & Chinese Robotics Company Soars in Shanghai Debut 8/19/26
Squawk on the Street
- Published
- August 19, 2026
- Duration
- 43:12
- Summary source
- description
- Last updated
- Aug 19, 2026
Discusses investing.
Summary
As shares of Moderna and Merck surge on new vaccine trial data, we speak to a top analyst about why he thinks the move higher is very difficult to rationalize. Then, Former CEA Chair Jason Furman discusses the Treasury Department's new debt buyback operations. Plus, we bring you the details of Chinese robotics company Unitree soaring in its public debut i…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
As shares of Moderna and Merck surge on new vaccine trial data, we speak to a top analyst about why he thinks the move higher is very difficult to rationalize. Then, Former CEA Chair Jason Furman discusses the Treasury Department's new debt buyback operations. Plus, we bring you the details of Chinese robotics company Unitree soaring in its public debut in Shanghai. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection
Themes
- investing